Two Seas Capital LP has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $5.03 Billion distributed in 49 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Roivant Sciences Ltd. with a value of $178M, Immunovant, Inc. with a value of $76M, First Solar, Inc. with a value of $75.1M, Gannett Co., Inc. with a value of $58.6M, and Sotera Health CO with a value of $53.1M.

Examining the 13F form we can see an decrease of $336M in the current position value, from $5.37B to 5.03B.

Two Seas Capital LP is based out at Rye, NY

Below you can find more details about Two Seas Capital LP portfolio as well as his latest detailed transactions.

Portfolio value $5.03 Billion
ETFs: $4.24 Billion
Healthcare: $425 Million
Technology: $106 Million
Communication Services: $76.4 Million
Financial Services: $70 Million
Utilities: $62.1 Million
Energy: $44.3 Million
Industrials: $8.77 Million
Other: $0

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 49
  • Current Value $5.03 Billion
  • Prior Value $5.37 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 7 stocks
  • Additional Purchases 16 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Two Seas Capital LP Portfolio

Follow Two Seas Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Seas Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Seas Capital LP with notifications on news.